ORGANIGRAM GLOBAL INC.
ORGANIGRAM GLOBAL INC is a Healthcare company operating in Drug Manufacturers - Specialty & Generic with a $135.1M market cap.
Most recent earnings call: Q1 FY26 on Feb 10, 2026.
21 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-06-21.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Spoken Alpha tracks OGI's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 70% positive reaction rate
SamplePeers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for OGI.
$ curl https://api.spokenalpha.com/v1/companies/OGIFAQ
Spoken Alpha indexes OGI's earnings call transcripts at https://spokenalpha.com/companies/OGI. Each call links to attributed speakers and parsed analyst Q&A. ORGANIGRAM GLOBAL INC.'s own investor relations page is at https://www.organigram.ca/investors.
ORGANIGRAM GLOBAL INC. (OGI) held its most recent earnings call on 2026-02-10, covering fiscal Q1 2026.
ORGANIGRAM GLOBAL INC. (OGI) operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
Consistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $2.23 | $1.68 | +32.5% | +0.7% | +1.5% |
| Q4 FY2026 | $2.47 | $1.85 | +33.7% | +5.0% | +4.6% |
| Q3 FY2026 | $2.68 | $1.88 | +42.8% | -4.7% | -3.1% |
| Q2 FY2026 | $2.41 | $1.74 | +38.6% | +0.7% | -0.9% |
| Q1 FY2025 | $2.71 | $1.91 | +41.7% | -1.3% | -3.8% |
| Q4 FY2025 |
| $2.71 |
| $1.99 |
| +36.3% |
| +2.3% |
| +4.3% |
| Q3 FY2025 | $2.97 | $2.03 | +46.5% | +1.5% | -0.9% |
| Q2 FY2025 | $2.52 | $1.91 | +32.0% | -1.9% | -1.9% |
| Q1 FY2024 | $3.02 | $2.10 | +43.8% | +6.6% | +3.7% |
| Q4 FY2024 | $2.74 | $2.00 | +37.0% | +5.0% | +2.4% |